Dr Vishal Navani

MA (Oxon) MBBS MRCP FRACP

Positions

Medical Oncologist

Arthur J.E. Child Comprehensive Cancer Centre

Member

Arnie Charbonneau Cancer Institute, Riddell Centre for Cancer Immunotherapy

Early Phase & Lung Cancer Clinical Trials Lead

Alberta Health Services

Affiliations

Clinical Assistant Professor

Cumming School of Medicine, Department of Oncology

Contact information

Vishal.Navani@ucalgary.ca

Web presence

Glans Look Lung Database

Phone number

Office: 587-231-5096

Location

Arthur Child Cancer Centre: Physicians Offices Level 10

For media enquiries, contact

Kelly Johnston
Senior Communications Specialist

Please submit your media request here

Preferred method of communication

Administrative Assistant

Yana Kada

Email: yana.kada@ahs.ca
Office: 587-231-5096

Background

Educational Background

Master of Arts Medical Sciences, University of Oxford,

Bachelor of Medicine Bachelor of Surgery Imperial College London,

Member of the Royal Colleges of Physicians UK Internal Medicine,

Fellow of the Royal Australasian College of Physicians Medical Oncology,

Biography

Dr. Vishal Navani is a Medical Oncologist at Arthur Child Cancer Centre, Calgary, Canada, and an Assistant Professor at the Cumming School of Medicine, University of Calgary, Calgary, Canada. He completed residency training in adult medical oncology & internal medicine, receiving fellowship of the Royal Australasian College of Physicians. He also holds Membership of the Royal College of Physicians (UK). Prior to his joint academic and clinical appointment in Calgary, he held a conjoint lectureship at the University of New South Wales, Sydney, Australia. He holds a Master of Arts (with honours) from the University of Oxford, UK and a Bachelor of Medicine & Bachelor of Surgery (with honours) from Imperial College London, UK.

In Calgary he leads the early phase & thoracic malignancy clinical trials divisions, sits on the data safety & monitoring committee and chairs the IIT funding committee. He is a member of the Canadian Drug Agency Clinical Expert Panel, providing expert input for HTA analysis of novel pharmaceutical submissions. Academically, he is the Director of Glans-Look Research, Canada’s largest thoracic malignancy real world evidence database. He has been PI on 8 trials & co-investigator on 18 trials across phases IA – III of the clinical development spectrum in thoracic & genitourinary malignancies & early phase clinical development. He currently leads Canada’s national recruitment in EVOLVE-LUNG-02, SGN-B6A & PACIFIC-8.

He has 82 published peer reviewed abstracts & manuscripts, with a H-Index of 13. He has received $1,300,000 in competitive grant funding. His work has been published in high profile journals such as the Lancet Oncology, Journal of Clinical Oncology & JAMA Oncology. He has authored 2 book chapters. He sits as an editorial review board member of Therapeutic Advances in Medical Oncology and peer reviewer for the JCO. He has won ASCO merit awards and authored pieces that have presented as Oral Presentations at the World Congress on Lung Cancer (Singapore 2024).

He sites on the national Canadian advisory boards for Janssen, AstraZeneca, BMS, Merck, Ipsen, Roche, Boehringer Ingelheim, Pfizer & Takeda, providing clinical development & medical affairs consultancy. He also provides clinical development advice & business development support to Novotech (CRO).